Results 241 to 250 of about 12,890,416 (254)

Immune-Related Adverse Events with PD-1 Versus PD-L1 Inhibitors: A Meta-Analysis of 8730 Patients from Clinical Trials

Future Oncology, 2021
Petros Grivas
exaly  

Rheumatic Immune-Related Adverse Events due to Immune Checkpoint Inhibitors—A 2023 Update

International Journal of Molecular Sciences, 2023
Ryu Watanabe, Tadashi Okano, Motomu Hashimoto   +2 more
exaly  

Immune Related Adverse Events of the Thyroid – A Narrative Review

Frontiers in Endocrinology, 2022
Alexander M Menzies, Christopher Muir, Roderick Clifton-Bligh   +2 more
exaly  

Neutrophil to Lymphocyte ratio as a predictor for immune-related adverse events in cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis

Frontiers in Immunology, 2023
Yifei Tan
exaly  

Safety of resuming anti-PD-1 in patients with immune-related adverse events (irAEs) during combined anti-CTLA-4 and anti-PD1 in metastatic melanoma

Annals of Oncology, 2018
Alexander M Menzies, Georgina V Long, D B Johnson   +2 more
exaly  

Immune-related adverse events with immune checkpoint blockade: a comprehensive review

European Journal of Cancer, 2016
Aurélien Marabelle, Caroline Robert, Michot Jm   +2 more
exaly  

Immune-Related Adverse Events Associated with Anti-PD-1/PD-L1 Treatment for Malignancies: A Meta-Analysis

Frontiers in Pharmacology, 2017
Showwei Li, Si-Ying Song
exaly  

Association Between Immune-Related Adverse Events During Anti–PD-1 Therapy and Tumor Mutational Burden

JAMA Oncology, 2019
Omar Hasan Ali, Lukas Flatz, Andrew Bate   +2 more
exaly  

Association between immune-related adverse events and long-term survival outcomes in patients treated with immune checkpoint inhibitors

European Journal of Cancer, 2020
Maillet Denis, Pauline Corbaux, Julien Peron   +2 more
exaly  

Current Diagnosis and Management of Immune Related Adverse Events (irAEs) Induced by Immune Checkpoint Inhibitor Therapy

Frontiers in Pharmacology, 2017
Mohit Garg, Charalampos S Floudas, Abhinav B Chandra   +2 more
exaly